The relationship between fasting plasma glucose and HbA1c during intensive periods of glucose control in antidiabetic therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Theoretical Biology

• Publication date

  2014-12-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jtbi.2014.08.020PMID 25158164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers

  2016cited by this paper
• Treatment of hyperglycaemia in newly diagnosed diabetic patients is associated with a reduction in oxidative stress and improvement in β‐cell function

  2014cited by this paper
• Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments

  2013cited by this paper
• Standards of Medical Care in Diabetes—2014

  2013cited by this paper
• Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes.

  2012cited by this paper
• Ethnicity modifies the relation between fasting plasma glucose and HbA1c in Indians, Malays and Chinese

  2012cited by this paper
• A Two-Step Screening, Measurement of HbA1c in Association with FPG, May Be Useful in Predicting Diabetes

  2012cited by this paper
• Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients

  2012cited by this paper
• The Pros and Cons of Diagnosing Diabetes With A1C

  2011cited by this paper
• A1C for Screening and Diagnosis of Type 2 Diabetes in Routine Clinical Practice

  2010cited by this paper
• The Effect of Oral Antidiabetic Agents on A1C Levels

  2010cited by this paper
• Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

  2009cited by this paper
• Translating the A1C Assay Into Estimated Average Glucose Values

  2009cited by this paper
• Translating the A1C Assay Into Estimated Average Glucose Values

  2008cited by this paper
• Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.

  2008cited by this paper
• Models for Plasma Glucose, HbA1c, and Hemoglobin Interrelationships in Patients with Type 2 Diabetes Following Tesaglitazar Treatment

  2008influential reference
• HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review

  2007cited by this paper
• HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

  2007cited by this paper
• Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial.

  2006cited by this paper
• Assessment of the relationship between glucose and A1c using kinetic modeling.

  2006influential reference
• A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus

  2006cited by this paper
• Treatment of the patient with diabetes: importance of maintaining target HbA1c levels

  2004cited by this paper
• Is HbA(1c) affected by glycemic instability?

  2003cited by this paper
• Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.

  2002cited by this paper
• How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?

  1999influential reference
• Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects.

  1999cited by this paper
• Nonfasting Plasma Glucose is a Better Marker of Diabetic Control Than Fasting Plasma Glucose in Type 2 Diabetes

  1997cited by this paper
• A pharmacodynamic model of erythropoietin therapy for uremic anemia

  1992cited by this paper
• Computer models of albumin and haemoglobin glycation.

  1990cited by this paper
• Application of a biokinetic model for prediction and assessment of glycated haemoglobins in diabetic patients.

  1988cited by this paper
• The clinical information value of the glycosylated hemoglobin assay.

  1984cited by this paper
• Glucosylation of human haemoglobin A. Dynamic variation in HbA1c described by a biokinetic model.

  1984cited by this paper
• Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes

  1982cited by this paper
• Kinetic analysis of the nonenzymatic glycosylation of hemoglobin.

  1981influential reference
• Home blood glucose concentrations in maturity-onset diabetes.

  1980influential reference
• A theoretical model to predict the behavior of glycosylated hemoglobin levels.

  1979influential reference
• HÆMOGLOBIN A1: AN INDICATOR OF THE METABOLIC CONTROL OF DIABETIC PATIENTS

  1977cited by this paper

• Therapeutic overview of sudachitin

  2024cites this paper
• Comparative Assessment Of Fasting Plasma Glucose And Hba1c Values In Type Ii Diabetes Mellitus In A Tertiary Care Hospital

  2022cites this paper
• Sudachi peel extract powder including the polymethoxylated flavone sudachitin improves visceral fat content in individuals at risk for developing diabetes

  2021cites this paper
• Different Analysis of β-Cell Dysfunction as Fasting Glucose Progresses in Obese and Nonobese Newly Diagnosed Type 2 Diabetic Patients

  2019cites this paper
• Correlation between hemoglobin A 1 c and lipid profile in Bosnian diabetic patients-gender differences

  2018cites this paper
• Steady-state relationship between average glucose, HbA1c and RBC lifespan.

  2018cites this paper
• The correlation between disordered lipid profile ( dyslipedemia ) and progression of diabetes mellitus type 2

  2017cites this paper
• Circulating Betatrophin and Hepatocyte Growth Factor in Type 2 Diabetic Patients: Their Relationship With Disease Prognosis

  2017cites this paper
• Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes—A Randomized Controlled Trial

  2017cites this paper
• Simulation of a computed HbA1c using a weighted average glucose

  2016cites this paper
• Toxicology and Oral glucose Tolerance Test (OGTT) of Thai Medicinal Plant Used for Diabetes controls, Phyllanthus acidus L. (EUPHORBIACEAE)

  2016cites this paper
• Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring

  2016cites this paper